New onset diabetic retinopathy with glucagon-like peptide-1 receptor agonists: A case report.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- New onset diabetic retinopathy with glucagon-like peptide-1 receptor agonists: A case report.
- Published In:
- Journal of the American Pharmacists Association : JAPhA, 65(5), 102475 (2025)
- Authors:
- Ko, Jennifer, Jahromi, Yaseman
- Database ID:
- RPEP-11874
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11874APA
Ko, Jennifer; Jahromi, Yaseman. (2025). New onset diabetic retinopathy with glucagon-like peptide-1 receptor agonists: A case report.. Journal of the American Pharmacists Association : JAPhA, 65(5), 102475. https://doi.org/10.1016/j.japh.2025.102475
MLA
Ko, Jennifer, et al. "New onset diabetic retinopathy with glucagon-like peptide-1 receptor agonists: A case report.." Journal of the American Pharmacists Association : JAPhA, 2025. https://doi.org/10.1016/j.japh.2025.102475
RethinkPeptides
RethinkPeptides Research Database. "New onset diabetic retinopathy with glucagon-like peptide-1 ..." RPEP-11874. Retrieved from https://rethinkpeptides.com/research/ko-2025-new-onset-diabetic-retinopathy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.